ACL (ACL): Results for Last 10 Financial Years (Summary)

Australian Clinical Labs Limited

ASX (AUD): Australian Clinical Labs Limited (ACL)

Last Price

3.54

Today's Change

+0.04 (1.14%)

Day's Change

3.45 - 3.56

Trading Volume

364,548

Financial

Market Cap

709 Million

Shares Outstanding

199 Million

Latest Quarter

30-Jun-2024 [Q4]

Announcement Date

28-Jun-2024

Reported Currency

AUD

Revenue QoQ | YoY

0.00% | -46.68%

NP QoQ | YoY

0.00% | -9.44%

Latest Audited

30-Jun-2024

Announcement Date

28-Jun-2024

Reported Currency

AUD

Revenue | Net Profit

689,728,000.00 | 23,934,000.00

EPS | EPS Diluted

0.12 Cent | 0.12 Cent

YoY

-33.33%

NP Margin

3.47%

Reported Currency in AUD

Show?

YoY %

Horiz. %

	30/06/24	30/06/23	30/06/22	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	CAGR
Last 10 FY Result (Thousand)
Revenue	689,728	692,103	989,298	641,311	487,530	445,890	376,088	339,768	10.63%
YoY %	-0.34%	-30.04%	54.26%	31.54%	9.34%	18.56%	10.69%	-	-
Horiz. %	203.00%	203.70%	291.17%	188.75%	143.49%	131.23%	110.69%	100.00%	-
PBT	36,366	48,310	254,900	86,653	30,891	-9,704	-7,641	-27,612	-
YoY %	-24.72%	-81.05%	194.16%	180.51%	418.33%	-27.00%	72.33%	-	-
Horiz. %	-131.70%	-174.96%	-923.15%	-313.82%	-111.88%	35.14%	27.67%	100.00%	-
Tax	12,122	12,268	76,498	26,264	-10,425	820	1,371	3,581	19.01%
YoY %	-1.19%	-83.96%	191.27%	351.93%	-1,371.34%	-40.19%	-61.71%	-	-
Horiz. %	338.51%	342.59%	2,136.22%	733.43%	-291.12%	22.90%	38.29%	100.00%	-
NP	23,934	35,901	178,244	60,373	41,255	-10,524	-9,012	-24,031	-
YoY %	-33.33%	-79.86%	195.24%	46.34%	492.01%	-16.78%	62.50%	-	-
Horiz. %	-99.60%	-149.39%	-741.73%	-251.23%	-171.67%	43.79%	37.50%	100.00%	-
Tax Rate	-33.33%	-25.39%	-30.01%	-30.31%	33.75%	-	-	-	-
YoY %	-31.27%	15.39%	0.99%	-189.81%	0.00%	-	-	-	-
Horiz. %	-98.76%	-75.23%	-88.92%	-89.81%	100.00%	-	-	-	-
Total Cost	665,794	656,202	811,054	580,938	446,275	456,414	385,100	363,799	9.01%
YoY %	1.46%	-19.09%	39.61%	30.17%	-2.22%	18.52%	5.86%	-	-
Horiz. %	183.01%	180.37%	222.94%	159.69%	122.67%	125.46%	105.86%	100.00%	-

	30/06/24	30/06/23	30/06/22	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	CAGR
Ratio Analysis
NP Margin	3.47	5.19	18.02	9.41	8.46	-2.36	-2.40	-7.07	-
YoY %	-33.14%	-71.20%	91.50%	11.23%	458.47%	1.67%	66.05%	-	-
Horiz. %	-49.08%	-73.41%	-254.88%	-133.10%	-119.66%	33.38%	33.95%	100.00%	-

	30/06/24	30/06/23	30/06/22	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	CAGR
Per Share
EPS	0.12	0.18	0.89	0.40	0.20	-0.05	-0.04	-0.12	-
YoY %	-33.33%	-79.78%	122.50%	100.00%	500.00%	-25.00%	66.67%	-	-
Horiz. %	-100.00%	-150.00%	-741.67%	-333.33%	-166.67%	41.67%	33.33%	100.00%	-
EPS Diluted	0.12	0.18	0.88	0.40	0.20	-0.05	-0.04	-0.12	-
YoY %	-33.33%	-79.55%	120.00%	100.00%	500.00%	-25.00%	66.67%	-	-
Horiz. %	-100.00%	-150.00%	-733.33%	-333.33%	-166.67%	41.67%	33.33%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Latest Videos